Thomas Ebeling - Net Worth and Insider Trading

Thomas Ebeling Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas Ebeling owns 1 companies in total, including Cullinan Therapeutics Inc (CGEM) .

Click here to see the complete history of Thomas Ebeling’s form 4 insider trades.

Insider Ownership Summary of Thomas Ebeling

Ticker	Comapny	Transaction Date	Type of Owner
CGEM	Cullinan Therapeutics Inc	2021-01-07	director

Thomas Ebeling Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Thomas Ebeling Ownership Network

Ownership Network List of Thomas Ebeling

No Data

Ownership Network Relation of Thomas Ebeling

Thomas Ebeling Owned Company Details

What does Cullinan Therapeutics Inc do?

Who are the key executives at Cullinan Therapeutics Inc?

Thomas Ebeling is the director of Cullinan Therapeutics Inc. Other key executives at Cullinan Therapeutics Inc include See Remarks Jennifer Michaelson , Acting Chief Business Officer Savill Corrine , and director & President and CEO Nadim Ahmed .

Cullinan Therapeutics Inc (CGEM) Insider Trades Summary

Over the past 18 months, Thomas Ebeling made no insider transaction in Cullinan Therapeutics Inc (CGEM). Other recent insider transactions involving Cullinan Therapeutics Inc (CGEM) include a net sale of 102,903 shares made by Jennifer Michaelson , a net sale of 5,708 shares made by Jeffrey Trigilio , and a net sale of 3,027 shares made by Jeffrey Alan Jones .

In summary, during the past 3 months, insiders sold 16,000 shares of Cullinan Therapeutics Inc (CGEM) in total and bought 0 shares, with a net sale of 16,000 shares. During the past 18 months, 239,648 shares of Cullinan Therapeutics Inc (CGEM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 239,648 shares.

Cullinan Therapeutics Inc (CGEM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cullinan Therapeutics Inc Insider Transactions

No Available Data

Thomas Ebeling Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas Ebeling. You might contact Thomas Ebeling via mailing address: C/o Idenix Pharmaceuticals, Inc., 60 Hampshire Street, Cambridge Ma 02139.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.